Source: Eur Respir J, 53 (3) 19E5303; 10.1183/13993003.E5303-2019



Rating:

Share or cite this content

Citations should be made in the following way:
ERJ March Podcast: Novel therapies in idiopathic pulmonary fibrosis. Eur Respir J, 53 (3) 19E5303; 10.1183/13993003.E5303-2019

Member's Comments

No comment yet.

Related content which might interest you: ERJ January Podcast: clinical guidelines for chronic pulmonary aspergillosis Source: Eur Respir J 2016; 47: E61 Year: 2016 ERJ October Podcast: new guidelines for diagnosis and treatment of pulmonary hypertension Source: Eur Respir J 2015; 46: E58 Year: 2015 ERJ June Podcast: unfavourable effects of oral anticoagulants on survival in idiopathic pulmonary fibrosis Source: Eur Respir J 2016; 47:E66 Year: 2016 ERJ June Podcast: Chronic pulmonary aspergillosis complicating sarcoidosis Source: Eur Respir J, 49 (6) 17E4906; 10.1183/13993003.E4906-2017 Year: 2017 ERJ August Podcast: management of chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2016; 48: E68 Year: 2016 Pirfenidone in idiopathic pulmonary fibrosis (IPF): Early Spanish experience with the European Named patient program (NPP) Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Development of the interstitial lung disease multidiciplinary team meeting 2005-2013 Source: International Congress 2015 – Kaleidoscope of nursing research Year: 2015 ERJ November Podcast: Macrolides in severe asthma Source: Eur Respir J, 54 (5) 19E5405; 10.1183/13993003.E5405-2019 Year: 2019 Talk from Warsaw – Tailoring drug therapy in idiopathic pulmonary fibrosis Source: ERS Satellites 2019 Year: 2019 Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis: Comparison with COPD Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions Year: 2013 IPF Care, a support program for patients with idiopathic pulmonary fibrosis in the UK Source: International Congress 2015 – Latest insights into chronic care Year: 2015 Nintedanib for idiopathic pulmonary fibrosis (IPF): Data from the German compassionate use program (CUP) Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 ERJ February Podcast: precision medicine in chronic airway diseases Source: Eur Respir J 2016; 47: E62 Year: 2016 Mechanisms of treatment response to pirfenidone of idiopathic pulmonary fibrosis (IPF) patients Source: International Congress 2016 – IPF pathogenesis Year: 2016 Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines Source: Eur Respir Rev 2014; 23:193-214 Year: 2014 Disease stratification in idiopathic pulmonary fibrosis: the dawn of a new era? Source: Eur Respir J 2014; 43: 1233-1236 Year: 2014 Japanese guideline for the treatment of idiopathic pulmonary fibrosis 2017 Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 Pirfenidone in idiopathic pulmonary fibrosis - description of a German cohort Source: International Congress 2014 – ILDs 4 Year: 2014 European idiopathic pulmonary fibrosis Patient Charter: a missed opportunity Source: Eur Respir J 2016; 48: 283-284 Year: 2016 Genetics in idiopathic pulmonary fibrosis Source: International Congress 2016 – GR3 Scientific Grand Round: precision medicine Year: 2016